Suchergebnisse - "Oh, In-Jae"

PubPharm (19)

1

Nicotinamide in Combination with EGFR-TKIs for the Treatment of Stage IV Lung Adenocarcinoma with EGFR Mutations : A Randomized Double-Blind (Phase IIb) Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Oh, H. | Bae, S. | Oh, I. | +7

2

A phase II, multicenter study of lazertinib as consolidation therapy in patients with locally advanced, unresectable, EGFR mutation-positive non-small cell lung cancer (stage III) who have not progressed following definitive, platinum-based, chemoradiation therapy (PLATINUM trial)

enthalten in: Thoracic cancer | 2022

von Choi, J. | Lee, J. | Choi, C. | +8

3

New strategy for suppressing the growth of lung cancer cells harboring mutations in the ATP-binding region of EGFR by targeting the molecular motor MYO1D

enthalten in: Clinical and translational medicine | 2021

von Ko, Y. | Kang, H. | Bae, J. | +9

4

Phase II open-label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA : Liquid-Lung-A

enthalten in: Thoracic cancer | 2021

von Park, C. | Lee, S. | Lee, J. | +5

5

Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma

enthalten in: BMC cancer | 2020

von Kang, D. | Jung, S. | Yeo, M. | +8

6

Feasibility of liquid biopsy using plasma and platelets for detection of anaplastic lymphoma kinase rearrangements in non-small cell lung cancer

enthalten in: Journal of cancer research and clinical oncology | 2019

von Park, C. | Kim, J. | Kim, M. | +8

7

A Phase II Trial of Osimertinib in the Second-Line Treatment of Non-small Cell Lung Cancer with the EGFR T790M Mutation, Detected from Circulating Tumor DNA : LiquidLung-O-Cohort 2

enthalten in: Cancer research and treatment | 2019

von Park, C. | Cho, H. | Choi, Y. | +2

8

Co-alteration of EGFR mutation and ALK rearrangement in non-small cell lung cancer : Case series

enthalten in: Medicine | 2019

von Shin, H. | Kho, B. | Kim, M. | +8

9

Clinical Activity of Pan-HER Inhibitors Against HER2-Mutant Lung Adenocarcinoma

enthalten in: Clinical lung cancer | 2018

von Oh, I. | Hur, J. | Park, C. | +7

10

Feasibility of re-biopsy and EGFR mutation analysis in patients with non-small cell lung cancer

enthalten in: Thoracic cancer | 2018

von Kim, T. | Oh, I. | Kho, B. | +10